<DOC>
	<DOC>NCT02566291</DOC>
	<brief_summary>In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.</brief_summary>
	<brief_title>Observational Study With Investigation of Two Second Generation Laryngeal Masks</brief_title>
	<detailed_description>After approval from the local ethics committee, data were collected in a prospective, non- randomised study over a three-month period. When contra-indications for laryngeal mask use were absent anaesthesiologists used either Supreme (Teleflex Medical GmbH, Germany) or Gain (Ambu GmbH, Germany). Endpoints were the success rate and time to insertion.</detailed_description>
	<mesh_term>Airway Remodeling</mesh_term>
	<criteria>Age â‰¥ 18 Years No concurrent participation in another study capacity to consent Present written informed consent of the research participant Elective surgery under general anesthesia Age &lt;18 years Existing pregnancy Lack of consent inability to consent emergency patients Emergency situations in the context of a Difficult Airway Management ASA classification&gt; 3 situations where the possibility of accumulated gastric contents Participation in another study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>laryngeal mask</keyword>
	<keyword>airway leakage</keyword>
	<keyword>airway morbidity</keyword>
</DOC>